The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Androgens improve cavernous vasodilation and response to sildenafil in patients with erectile dysfunction
Abstract
Summary: objectives We have recently shown that, in men with erectile dysfunction (ED), free testosterone (FT) directly correlates with penile arterial inflow. This led us to further investigate the effect(s) of androgen administration on cavernous arteries in patients failing sildenafil treatment. design Prospective randomized placebo‐controlled pilot study. patients Twenty patients with arteriogenic ED as evaluated by dynamic colour duplex ultrasound (D‐CDU) studies, normal sexual desire but testosterone (T) and FT in the lower quartile of normal range (low‐normal), not responding to sildenafil treatment (100 mg) on six consecutive attempts. measurements All patients had D‐CDU, hormonal [LH, prostate‐specific antigen (PSA), total and free testosterone, sex hormone‐binding protein (SHBG), oestradiol], biochemical [haematocrit, low‐density lipoprotein (LDL) and HDL cholesterol, triglycerides], and sexual evaluations [International Index of Erectile Function (IIEF)] before and after 1 month of therapy with transdermal testosterone (5 mg/day, n = 10) or placebo along with sildenafil treatment on demand. Measurement of flow parameters by D‐CDU on cavernous arteries was the primary endpoint of the study. Improvement of erectile function was assessed using the IIEF questionnaire and the Global Assessment Question (GAQ). results One month treatment with transdermal testosterone led to a significant increase in T and FT levels (23·7 ± 3·3 SD vs. 12·8 ± 2·1 nmol/l and 473 ± 40·2 vs. 260 ± 18·1 pmol/l, P < 0·01, respectively). In addition testosterone administration induced a significant increase in arterial inflow to cavernous arteries measured by D‐CDU (32 ± 3·6 vs. 25·2 ± 4 cm/s, P < 0·05), with no adverse effects. Also, a significant improvement in erectile function domain score at IIEF was found in the androgen but not in the placebo‐treated patients (21·8 ± 2·1 vs. 14·4 ± 1·4, P < 0·05) which was associated with significant changes in the GAQ score (80%vs. 10%, P < 0·01). conclusions In patients with arteriogenic ED and low‐normal androgen levels, short‐term testosterone administration increases T and FT levels and improves the erectile response to sildenafil likely by increasing arterial inflow to the penis during sexual stimulation.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Testosterone replacement therapy in two studies was found to convert sildenafil nonresponders to responders (18,19).”
From Clinical and Biochemical Assessment of Hypogonadism in Men With Type 2 Diabetes (2007) · cites this paper as [19]
Citations
Cites
Rosen, R. C., Riley, A., Wagner, G., Osterloh, I. H., Kirkpatrick, J., & Mishra, A. (1997) · Urology · doi:10.1016/s0090-4295(97)00238-0 · Cited by 5,849
Effects of Testosterone on Coronary Vasomotor Regulation in Men With Coronary Heart Disease
Webb, C. M., McNeill, J. G., Hayward, C. S., de Zeigler, D., & Collins, P. (1999) · Circulation · doi:10.1161/01.cir.100.16.1690 · Cited by 451
KWAN, M., GREENLEAF, W. J., MANN, J., CRAPO, L., & DAVIDSON, J. M. (1983) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-57-3-557 · Cited by 339
Effects of Castration and Androgen Replacement on Erectile Function in a Rabbit Model1
Traish, A. M., Park, K., Dhir, V., Kim, N. N., Moreland, R. B., & Goldstein, I. (1999) · Endocrinology · doi:10.1210/endo.140.4.6655 · Cited by 305
Changes in erectile responsiveness during androgen replacement therapy
Bancroft, J., & Wu, F. C. W. (1983) · Archives of Sexual Behavior · doi:10.1007/bf01542116 · Cited by 288
Lugg, J., Rajfer, J., & González-Cadavid, N. F. (1995) · Endocrinology · doi:10.1210/endo.136.4.7534702 · Cited by 278
Effect of acute testosterone on myocardial ischemia in men with coronary artery disease
Webb, C. M., Adamson, D. L., de Zeigler, D., & Collins, P. D. (1999) · The American Journal of Cardiology · doi:10.1016/s0002-9149(98)00880-7 · Cited by 242
The effects of exogenous testosterone on sexuality and mood of normal men.
Anderson, R. A., Bancroft, J., & Wu, F. C. (1992) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.75.6.1464655 · Cited by 238
Aversa, A., Isidori, A. M., Martino, M., Caprio, M., Fabbrini, E., March, M. R., Frajese, G., & Fabbri, A. (2000) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2000.01118.x · Cited by 205
Self-citationTestosterone Therapy for Low Sexual Interest and Erectile Dysfunction in Men: a Controlled Study
O'Carroll, R., & Bancroft, J. (1984) · British Journal of Psychiatry · doi:10.1192/bjp.145.2.146 · Cited by 188
Research works printed but not linked: 2
- 10.1210/jc.75.6.1503 · DOI · Paper page
- Bhasin S., 1998, Issues in testosterone replacement in older men, Journal of Clinical Endocrinology and Metabolism, 83, 3435
Cited by
Sorted by citations
Bhasin, S., Cunningham, G. R., Hayes, F. J., Matsumoto, A. M., Snyder, P. J., Swerdloff, R. S., & Montori, V. M. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-2354 · Cited by 1,954
The Decline of Androgen Levels in Elderly Men and Its Clinical and Therapeutic Implications
Kaufman, J. M., & Vermeulen, A. (2005) · Endocrine Reviews · doi:10.1210/er.2004-0013 · Cited by 1,079
Bhasin, S., Cunningham, G. R., Hayes, F. J., Matsumoto, A. M., Snyder, P. J., Swerdloff, R. S., & Montori, V. M. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-2847 · Cited by 965
Isidori, A. M., Giannetta, E., Greco, E. A., Gianfrilli, D., Bonifacio, V., Isidori, A., Lenzi, A., & Fabbri, A. (2005) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2005.02339.x · Cited by 695
Self-citationAssociation of Specific Symptoms and Metabolic Risks with Serum Testosterone in Older Men
Zitzmann, M., Faber, S., & Nieschlag, E. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-0401 · Cited by 552
Metadata
- Authors
- Aversa, A., Isidori, A. M., Spera, G., Lenzi, A., & Fabbri, A.
- Affiliations
- Sapienza University of Rome (IT)
- University of Rome Tor Vergata (IT)
- Venue
- Clinical Endocrinology
- Publisher
- Wiley
- Published
- 2003-05
- Volume
- 58
- Issue
- 5
- Pages
- 632-638
- ISSN
- 0300-0664 (ISSN-L)
- 1365-2265
- OpenAlex
- W1994273184
- Cited by
- 343
- References
- 38
- Citations by year
- 2025: 7 · 2024: 4 · 2023: 7 · 2022: 8 · 2021: 6 · 2020: 4 · 2019: 10 · 2018: 5 · 2017: 2 · 2016: 9 · 2015: 7 · 2014: 15 · 2013: 11 · 2012: 15
- FWCI
- 22.03
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Clinical Endocrinology (publishedVersion)
- PubMed (publishedVersion)
- IRIS Research product catalog (Sapienza University of Rome) (submittedVersion)
- Funders
- Ministero dell'Università e della Ricerca
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Sexual function and dysfunction studies
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal and reproductive studies
- Health Sciences › Medicine › Urology › Urological Disorders and Treatments
- Keywords
- erectile dysfunction, arteriogenic erectile dysfunction, transdermal testosterone, androgen therapy, free testosterone, erectile function, sex hormone-binding globulin, International Index of Erectile Function, sex hormones, estradiol
- MeSH terms
- Sildenafil Citrate, Aged, Androgens, Arteries, Humans, Male, Middle Aged, Penile Erection, Penis, Pilot Projects, Piperazines, Prospective Studies, Purines, Regional Blood Flow, Sulfones, Testosterone, Vasodilation, Vasodilator Agents, Treatment Failure, Impotence, Vasculogenic
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review